Table 3.
Univariate Analysis | Multivariable Analysis* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | SE | z | p-value | 95% CI | HR | SE | z | p-value | 95% CI | |
Donor Characteristics | ||||||||||
Diabetes | 1.447 | 0.025 | 21.53 | < 0.001 | 1.399-1.497 | 1.210 | 0.024 | 9.67 | < 0.001 | 1.164-1.258 |
ECD | 1.641 | 0.017 | 48.56 | < 0.001 | 1.608-1.674 | 1.573 | 0.019 | 37.92 | < 0.001 | 1.537-1.611 |
Obese (BMI >=30) | 1.069 | 0.011 | 6.59 | < 0.001 | 1.048-1.091 | |||||
Recipient Characteristics | ||||||||||
Age > 40 | 1.181 | 0.011 | 17.33 | < 0.001 | 1.159-1.203 | 1.008 | 0.012 | 0.67 | 0.505 | 0.985-1.031 |
Male | 1.115 | 0.009 | 13.09 | < 0.001 | 1.097-1.133 | 1.073 | 0.011 | 7.07 | < 0.001 | 1.052-1.094 |
African American Race | 1.355 | 0.012 | 35.29 | < 0.001 | 1.333-1.379 | 1.333 | 0.014 | 28.21 | < 0.001 | 1.306-1.359 |
Pre-Transplant Dialysis** | 1.029 | 0.001 | 25.72 | < 0.001 | 1.027-1.032 | |||||
Time on Waitlist (days) | 1.000 | 0.000 | 4.89 | < 0.001 | 1.000-1.000 | |||||
Repeat Renal Transplant | 1.048 | 0.013 | 3.69 | < 0.001 | 1.022-1.074 | |||||
HCV+ | 1.543 | 0.024 | 27.86 | < 0.001 | 1.497-1.591 | 1.458 | 0.026 | 21.54 | < 0.001 | 1.409-1.509 |
Max PRA ≥30 | 1.081 | 0.011 | 7.70 | < 0.001 | 1.060-1.103 | 1.119 | 0.014 | 8.97 | < 0.001 | 1.092-1.146 |
≥ 1 HLA Mismatch | 1.281 | 0.018 | 17.95 | < 0.001 | 1.246-1.316 | |||||
Pre-Transplant Diabetes** | 1.015 | 0.000 | 39.03 | < 0.001 | 1.014-1.015 | 1.012 | 0.000 | 30.90 | < 0.001 | 1.012-1.013 |
Obese (BMI >=30) | 1.150 | 0.011 | 15.31 | < 0.001 | 1.130-1.171 | |||||
Cold Ischemia Time | 1.007 | 0.000 | 14.24 | < 0.001 | 1.006-1.008 | |||||
Delayed Graft Function | 1.780 | 0.016 | 65.72 | < 0.001 | 1.750-1.811 | |||||
Acute Rejection at 1 Year | 1.592 | 0.017 | 43.48 | < 0.001 | 1.559-1.626 | |||||
No Induction Immunosuppression |
1.040 | 0.009 | 4.65 | < 0.001 | 1.023-1.058 | 1.116 | 0.012 | 10.57 | < 0.001 | 1.093-1.139 |
Tacrolimus and the interaction term between tacrolimus and time were also included in the multivariable model
Included as an interaction term along with duration of dialysis or diabetes, as appropriate